BioLift was shown through 3 clinical trials to increase productivity, reduce brain fog, and maintain clarity for higher performance. But, unlike its caffeinated competitors, BioLift does not increase pulse or blood pressure

The FDA has approved Evrysdi™ (risdiplam), the first at-home, orally administered treatment for spinal muscular atrophy in children and adults

the U.S. Food and Drug Administration approved Olinvyk (oliceridine), an opioid agonist for the management of moderate to severe acute pain in adults

The WATCHMAN FLX is the only FDA-approved device for the reduction of stroke risk in patients with non-valvular atrial fibrillation (A Fib).